Matthew Horsfall
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Matthew Horsfall has a total of 160 co-authors. Here are the top co-authors by number of shared publications:
- Derek Pb Chew
Victorian Heart Hospital, Monash Health, Melbourne, Victoria, Australia; Victorian Heart Institute, Monash University, Melbourne, Victoria, Australia
27 shared publications David Brieger
Department of Cardiology, Concord Hospital, Sydney, Australia
5 shared publicationsJohn French
Cardiology Department, Liverpool Hospital, Sydney, NSW, Australia
5 shared publications- Stephen Quinn
Department of Health Science and Biostatistics, Swinburne University of Technology, Melbourne, Australia
5 shared publications - Billingsley Kaambwa
Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Adelaide, Australia
4 shared publications Carolyn Astley
Associate Professor of Nursing, College of Nursing and Health Sciences, Flinders University; all in Bedford Park, South Australia
4 shared publications
Latest Publications
- Open Access
- 28 March 2023
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
- Vol. 2
The Incremental Value of Functional Testing for Acute Chest Pain Assessment in the Context of High-sensitivity Troponin T
Background: Functional testing for acute chest pain assessment is a common practice that has not been re-examined in the era of high-sensitivity cardiac troponin. This population poses a significant analytical dilemma for physicians to achieve accurate diagnosis, balanced against the inherent risks of hospital admission and invasive downstream testing. This single-centre study evaluated outcomes in patients who underwent chest pain assessment, whose initial diagnosis was not consistent with a MI, comparing subsequent functional testing versus no functional testing. Methods: An inverse probability propensity-matched analysis of patients who underwent chest pain assessment in the emergency department and not initially referred for coronary angiography was performed to examine whether functional testing was associated with a lower rate of death or MI at 30 days. Results: In total, 3,101 patients were included. Functional testing was performed in 986 patients, while 2,115 did not undergo functional testing. The quality of propensity matching for covariates was high. The overall event rate of all-cause mortality and MI was low, totalling at five events. There was no significant difference between those who underwent functional testing versus those who did not undergo functional testing. Conclusion: Functional testing is not likely to be associated with a reduced risk of death or MI within 30 days, and provides limited further diagnostic benefit in the acute timeframe in the context of high-sensitivity cardiac troponin testing.
- 28 March 2023
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
- Vol. 2
Open AccessThe Incremental Value of Functional Testing for Acute Chest Pain Assessment in the Context of High-sensitivity Troponin T
Background: Functional testing for acute chest pain assessment is a common practice that has not been re-examined in the era of high-sensitivity cardiac troponin. This population poses a significant analytical dilemma for physicians to achieve accurate diagnosis, balanced against the inherent risks of hospital admission and invasive downstream testing. This single-centre study evaluated outcomes in patients who underwent chest pain assessment, whose initial diagnosis was not consistent with a MI, comparing subsequent functional testing versus no functional testing. Methods: An inverse probability propensity-matched analysis of patients who underwent chest pain assessment in the emergency department and not initially referred for coronary angiography was performed to examine whether functional testing was associated with a lower rate of death or MI at 30 days. Results: In total, 3,101 patients were included. Functional testing was performed in 986 patients, while 2,115 did not undergo functional testing. The quality of propensity matching for covariates was high. The overall event rate of all-cause mortality and MI was low, totalling at five events. There was no significant difference between those who underwent functional testing versus those who did not undergo functional testing. Conclusion: Functional testing is not likely to be associated with a reduced risk of death or MI within 30 days, and provides limited further diagnostic benefit in the acute timeframe in the context of high-sensitivity cardiac troponin testing.
- Open Access
- 1 July 2021
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 10 (9) , 1038-1047
Classification performance of clinical risk scoring in suspected acute coronary syndrome beyond a rule-out troponin profile
High-sensitivity cardiac troponin strategies can provide risk stratification in patients with suspected acute coronary syndrome (ACS) in the emergency department (ED). This study evaluated whether clinical risk scoring improves the classification performance of a rule-out profile in suspected ACS. Patients presenting to ED with suspected ACS as part of the RAPID-TnT trial randomized to the intervention arm were included. Results 5 ng/L were available for all participants in this analysis. We evaluated the Thrombolysis In Myocardial Infarction (TIMI) risk score, History ECG Age Risk factors Troponin (HEART) score, and Emergency Department Assessment of Chest pain Score (EDACS) in addition to a rule-out profile based on the 0/1-h high-sensitivity cardiac troponin T protocol (<5 ng/L or 12 ng/L and a change of <3 ng/L at 1-h) using test performance parameters focusing on low-risk groups to identify the primary endpoint (TIMI 1, HEART 3, EDACS < 16). Primary endpoint was a composite of type 1/2 myocardial infarction (MI) at index presentation and all-cause mortality or type 1/2 MI at 30 days. A total of 3378 participants were enrolled between August 2015 and April 2019 of which 108 were ineligible/withdrew consent (intervention arm: n = 1638). Sensitivity, specificity, negative predictive value (NPV), and area under the curve (AUC) of the rule-out profile was 94.4%, 76.8%, 99.6%, and 0.86, respectively with 72.9% identified as ‘low-risk’. Adding the clinical risk scores did not improve the sensitivity, NPV, or AUC with significantly lower specificity and ‘low-risk’ classified participants. Addition of clinical risk scores to rule-out profile did not demonstrate improved classification performance for identifying the composite of type 1/2 MI at index presentation and all-cause mortality or type 1/2 MI at 30 days. URL: https://www.anzctr.org.au. Reg. No. ACTRN12615001379505.- 1 July 2021
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 10 (9) , 1038-1047
Open AccessClassification performance of clinical risk scoring in suspected acute coronary syndrome beyond a rule-out troponin profile
High-sensitivity cardiac troponin strategies can provide risk stratification in patients with suspected acute coronary syndrome (ACS) in the emergency department (ED). This study evaluated whether clinical risk scoring improves the classification performance of a rule-out profile in suspected ACS. Patients presenting to ED with suspected ACS as part of the RAPID-TnT trial randomized to the intervention arm were included. Results 5 ng/L were available for all participants in this analysis. We evaluated the Thrombolysis In Myocardial Infarction (TIMI) risk score, History ECG Age Risk factors Troponin (HEART) score, and Emergency Department Assessment of Chest pain Score (EDACS) in addition to a rule-out profile based on the 0/1-h high-sensitivity cardiac troponin T protocol (<5 ng/L or 12 ng/L and a change of <3 ng/L at 1-h) using test performance parameters focusing on low-risk groups to identify the primary endpoint (TIMI 1, HEART 3, EDACS < 16). Primary endpoint was a composite of type 1/2 myocardial infarction (MI) at index presentation and all-cause mortality or type 1/2 MI at 30 days. A total of 3378 participants were enrolled between August 2015 and April 2019 of which 108 were ineligible/withdrew consent (intervention arm: n = 1638). Sensitivity, specificity, negative predictive value (NPV), and area under the curve (AUC) of the rule-out profile was 94.4%, 76.8%, 99.6%, and 0.86, respectively with 72.9% identified as ‘low-risk’. Adding the clinical risk scores did not improve the sensitivity, NPV, or AUC with significantly lower specificity and ‘low-risk’ classified participants. Addition of clinical risk scores to rule-out profile did not demonstrate improved classification performance for identifying the composite of type 1/2 MI at index presentation and all-cause mortality or type 1/2 MI at 30 days. URL: https://www.anzctr.org.au. Reg. No. ACTRN12615001379505. - Open Access
- 1 February 2021
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 32, 100705
Impact of increased augmentation index and valvuloarterial impedance on symptom recovery after aortic valve replacement for severe aortic stenosis
- 1 February 2021
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 32, 100705
Open AccessImpact of increased augmentation index and valvuloarterial impedance on symptom recovery after aortic valve replacement for severe aortic stenosis
- Open Access
- 21 September 2020
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (18) , 6889
Quality of Life Changes in Acute Coronary Syndromes Patients: A Systematic Review and Meta-Analysis
There is little up-to-date evidence about changes in quality of life following treatment for acute coronary syndrome (ACS) patients. The main aim of this review was to assess the changes in QoL in ACS patients after treatment. We undertook a systematic review and meta-analysis of quantitative studies. The search included studies that described the change of QoL of ACS patients after receiving treatment options such as percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG) and medical therapy (MT). We synthesized findings using content analysis and pooled the estimates using meta-analysis. We used the PRISMA guidelines to select and appraise the studies and report the findings. Twenty-nine (29) articles were included in the review. We found a significant improvement of QoL in ACS patients after receiving treatment. Particularly, the meta-analytic association found that the mean QoL of patients diagnosed with ACS was higher after receiving treatment compared to baseline (overall pooled mean difference = 31.88; 95% CI = 31.64–52.11, I2 = 98) with patients on PCI having slightly lower QoL gains (pooled mean difference = 30.22; 95% CI = 29.9–30.53, I2 = 0%) compared to those on CABG (pooled mean difference = 34.01; 95% CI = 33.66–34.37, I2 = 0%). The review confirmed that QoL of ACS patients improved after receiving treatment therapies although varied by the treatment options and patients’ preferences. This suggests the need to perform further study on the QoL, patient preferences and physicians’ decision to prescription of treatment options.
- 21 September 2020
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (18) , 6889
Open AccessQuality of Life Changes in Acute Coronary Syndromes Patients: A Systematic Review and Meta-Analysis
There is little up-to-date evidence about changes in quality of life following treatment for acute coronary syndrome (ACS) patients. The main aim of this review was to assess the changes in QoL in ACS patients after treatment. We undertook a systematic review and meta-analysis of quantitative studies. The search included studies that described the change of QoL of ACS patients after receiving treatment options such as percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG) and medical therapy (MT). We synthesized findings using content analysis and pooled the estimates using meta-analysis. We used the PRISMA guidelines to select and appraise the studies and report the findings. Twenty-nine (29) articles were included in the review. We found a significant improvement of QoL in ACS patients after receiving treatment. Particularly, the meta-analytic association found that the mean QoL of patients diagnosed with ACS was higher after receiving treatment compared to baseline (overall pooled mean difference = 31.88; 95% CI = 31.64–52.11, I2 = 98) with patients on PCI having slightly lower QoL gains (pooled mean difference = 30.22; 95% CI = 29.9–30.53, I2 = 0%) compared to those on CABG (pooled mean difference = 34.01; 95% CI = 33.66–34.37, I2 = 0%). The review confirmed that QoL of ACS patients improved after receiving treatment therapies although varied by the treatment options and patients’ preferences. This suggests the need to perform further study on the QoL, patient preferences and physicians’ decision to prescription of treatment options.
- 1 March 2020
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 29 (3) , 475-482
The Impact of Cardiac Rehabilitation and Secondary Prevention Programs on 12-Month Clinical Outcomes: A Linked Data Analysis
- 1 March 2020
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 29 (3) , 475-482
The Impact of Cardiac Rehabilitation and Secondary Prevention Programs on 12-Month Clinical Outcomes: A Linked Data Analysis
- Open Access
Impact of patient’s health-related quality of life on physicians’ therapy and perceived benefit in acute coronary syndromes: protocol for a systemic review of quantitative and qualitative studies
Introduction Percutaneous coronary interventions (PCIs) and coronary angiography are two of the treatments administered to acute coronary syndrome (ACS) patients. However, whether and how patients’ health-related quality of life (HRQoL) influences treatment decisions and subsequent risk benefit analyses is unclear. In this study, we will review the available evidence on the impact of patients’ HRQoL on physicians’ prescribing or treatment decisions and on the estimation of mortality and bleeding risk in ACS patients. Methods and analysis We will undertake a systematic review of all quantitative and qualitative studies. The search will include studies that describe the impact of HRQoL on prescribing PCIs or angiography, and impact of HRQoL on perceived risks in terms of mortality and bleeding events. We will conduct an initial search on Google scholar and MEDLINE to build the searching terms followed by a full search strategy using all identified keywords and index terms across the five databases, namely MEDLINE, PubMed, CINAHL, SCOPUS and Web of Sciences. We will use the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for protocol guidelines to present the protocol. Only English language articles will be included for the review. We will use a standardised Joanna Briggs Institute data extraction tool to synthesise the information extracted from the selected studies into themes with summary findings presented in a table. Ethics and dissemination We will not require a formal ethical approval as we will not be collecting primary data. Review findings will be disseminated through a peer-reviewed publication, workshops, conference presentations and a media release. PROSPERO registration number CRD42018108438.
Open AccessImpact of patient’s health-related quality of life on physicians’ therapy and perceived benefit in acute coronary syndromes: protocol for a systemic review of quantitative and qualitative studies
Introduction Percutaneous coronary interventions (PCIs) and coronary angiography are two of the treatments administered to acute coronary syndrome (ACS) patients. However, whether and how patients’ health-related quality of life (HRQoL) influences treatment decisions and subsequent risk benefit analyses is unclear. In this study, we will review the available evidence on the impact of patients’ HRQoL on physicians’ prescribing or treatment decisions and on the estimation of mortality and bleeding risk in ACS patients. Methods and analysis We will undertake a systematic review of all quantitative and qualitative studies. The search will include studies that describe the impact of HRQoL on prescribing PCIs or angiography, and impact of HRQoL on perceived risks in terms of mortality and bleeding events. We will conduct an initial search on Google scholar and MEDLINE to build the searching terms followed by a full search strategy using all identified keywords and index terms across the five databases, namely MEDLINE, PubMed, CINAHL, SCOPUS and Web of Sciences. We will use the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for protocol guidelines to present the protocol. Only English language articles will be included for the review. We will use a standardised Joanna Briggs Institute data extraction tool to synthesise the information extracted from the selected studies into themes with summary findings presented in a table. Ethics and dissemination We will not require a formal ethical approval as we will not be collecting primary data. Review findings will be disseminated through a peer-reviewed publication, workshops, conference presentations and a media release. PROSPERO registration number CRD42018108438.
- Open Access
- 1 February 2019
- Published by Elsevier in American Heart Journal
- Vol. 208, 11-20
The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design
- 1 February 2019
- Published by Elsevier in American Heart Journal
- Vol. 208, 11-20
Open AccessThe appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design
- 2 October 2018
- Published by Mark Allen Group in British Journal of Cardiac Nursing
- Vol. 13 (10) , 498-505
Clinician assessment of acute coronary syndrome in the emergency department
Background: Patients with chest pain represent a large portion of emergency department (ED) presentations around the world. Accurate risk assessment to rule out acute coronary syndrome (ACS) is required. Aim: To measure accuracy and characteristics of ED doctors and nurses when assessing patients for suspected ACS and the associations with outcome. Methods: A sub-analysis of a large randomised trial that compared high-sensitivity troponin to conventional troponin was carried out. Both nurses and doctors conducted ACS risk assessments on 1857 patients and concordance comparisons were undertaken. Findings: There was no difference between the accuracy of ED nurses and doctors (c-statistic: 0.67 vs 0.68 respectively; P=0.35). Both clinician types made similar ACS risk assessments. Nurses with specialist qualifications and consultant doctors were the most accurate, at 65.4% and 74.2%, respectively. Conclusion: Nurses and doctors in the ED made similar ACS risk assessments but both were sub-optimal. Standard clinical pathways to assist ED doctors and nurses improve their ACS impression accuracy could be beneficial.
- 2 October 2018
- Published by Mark Allen Group in British Journal of Cardiac Nursing
- Vol. 13 (10) , 498-505
Clinician assessment of acute coronary syndrome in the emergency department
Background: Patients with chest pain represent a large portion of emergency department (ED) presentations around the world. Accurate risk assessment to rule out acute coronary syndrome (ACS) is required. Aim: To measure accuracy and characteristics of ED doctors and nurses when assessing patients for suspected ACS and the associations with outcome. Methods: A sub-analysis of a large randomised trial that compared high-sensitivity troponin to conventional troponin was carried out. Both nurses and doctors conducted ACS risk assessments on 1857 patients and concordance comparisons were undertaken. Findings: There was no difference between the accuracy of ED nurses and doctors (c-statistic: 0.67 vs 0.68 respectively; P=0.35). Both clinician types made similar ACS risk assessments. Nurses with specialist qualifications and consultant doctors were the most accurate, at 65.4% and 74.2%, respectively. Conclusion: Nurses and doctors in the ED made similar ACS risk assessments but both were sub-optimal. Standard clinical pathways to assist ED doctors and nurses improve their ACS impression accuracy could be beneficial.
- 1 October 2018
- Published by Elsevier in International Journal of Cardiology
- Vol. 269, 13-18
Invasive management of acute coronary syndrome: Interaction with competing risks
- 1 October 2018
- Published by Elsevier in International Journal of Cardiology
- Vol. 269, 13-18
Invasive management of acute coronary syndrome: Interaction with competing risks